Abstract: The vibration substrate having a main surface extending parallel to a first direction and a second direction that are orthogonal to each other, and that includes a main body region having a vibrating portion at least in a part thereof and at least one holding region arranged side by side with the main body region along the first direction. The at least one holding region including a holding portion and a beam portion connecting the holding portion and the main body region. The beam portion includes a first arm portion extending from the holding portion along the first direction, a second arm portion extending along the second direction from an end portion of the first arm portion on a side thereof opposite to the holding portion, and a connection portion connecting the second arm portion and the main body region.

Abstract: An object is to provide a drug which is useful in treating a nervous system disease. A drug containing vitamin B12 as an active ingredient according to the present invention has an M2 macrophage/microglia induction promoting effect, an M1 macrophage/microglia induction inhibiting effect, a nerve regeneration promoting effect, and the like and is very useful as a therapeutic agent for a nervous system disease, and particularly useful as a therapeutic agent for a central nervous system disease such as cerebral infarction, dementia, or spinal cord injury.

Abstract: A data recorder capable of reducing adverse effects caused by radiation is provided. In one aspect of a data recorder of the present disclosure, an input interface includes a first buffer memory, the input interface accepts input of data from outside and records the data in the first buffer memory, a control unit switches a state of a power supply for non-volatile memory to an on state at a timing determined on the basis of an amount of data recorded in the first buffer memory and a mode of the input of the data from the outside via the input interface, the input interface transfers the data recorded in the first buffer memory to the non-volatile memory in a case where the power supply for non-volatile memory is in an on state.

Abstract: In one non-limiting embodiment, the present disclosure relates to lyophilized formulations containing an IL-31 antagonist (for example, an anti-IL-31RA antibody) as an active ingredient, the lyophilized formulations further containing arginine and/or a salt thereof and sucrose and/or trehalose. In another non-limiting embodiment, the present disclosure relates to solution formulations containing an IL-31 antagonist as an active ingredient, the solution formulations further containing arginine and/or a salt thereof.

Abstract: Disclosed is a positive electrode material having inhibited increase in heat release when exposed to high temperature. The positive electrode material of the disclosure comprises a positive electrode active material, a first solid electrolyte and a second solid electrolyte, wherein the positive electrode active material comprises a lithium-containing oxide, the first solid electrolyte comprises Li and X as constituent elements and comprises no S, X is one or more elements selected from the group consisting of F, Cl, Br and I, the second solid electrolyte comprises Li and S as constituent elements, the first solid electrolyte covers at least part of the surface of the positive electrode active material, the second solid electrolyte contacts with the positive electrode active material across the first solid electrolyte, and the average covering thickness of the first solid electrolyte is 104 nm or greater.

Abstract: An object is to provide a drug which is useful in treating a nervous system disease. A drug containing vitamin B12 as an active ingredient according to the present invention has an M2 macrophage/microglia induction promoting effect, an M1 macrophage/microglia induction inhibiting effect, a nerve regeneration promoting effect, and the like and is very useful as a therapeutic agent for a nervous system disease, and particularly useful as a therapeutic agent for a central nervous system disease such as cerebral infarction, dementia, or spinal cord injury.

Abstract: A nerve stimulating apparatus includes a plurality of stimulating units configured to respectively apply stimuli to a plurality of nerve regions branching from a particular nerve region of a living body, and a stimulation timing controller configured to set generating timings of respectively generating the stimuli at the plurality of stimulating units. The stimulation timing controller sets the generating timings of generating the stimuli at the plurality of stimulating units based on response results of the particular nerve region, the response results being obtained in response to the stimuli that are respectively generated at the plurality of stimulating units and that are respectively applied to the plurality of nerve regions, and the response results being measured by a biometric information measuring apparatus that measures biometric information.

Abstract: To provide a molded product which has a high flexural modulus and is excellent in heat resistance and impact resistance at a low temperature; and a resin composition from which the molded product can be obtained. A resin composition comprising a polyaryl ether ketone, a fluorinated elastomer and an inorganic filler, wherein the proportion of the fluorinated elastomer to the total of the volume of the polyaryl ether ketone and the volume of the fluorinated elastomer, is from 1 to 45 vol %, the proportion of the inorganic filler is from 1 to 50 mass %, and the deflection temperature under load measured in accordance with ASTM D648 under a load of 1.

Abstract: Provided is a particle measuring method for measuring, based on image data containing an image of a plurality of particles, a size of each of the particles included in the image data. The particle measuring method includes: acquiring a position of each of the plurality of particles from the image data; extracting two particles vicinal to each other; and calculating the size of each of the particles based on a distance between the two vicinal particles.

Abstract: The present invention provides a novel compound that has anti-RSV activity and that is useful in the prevention or treatment of an infection in which viruses of the subfamily Pneumovirinae, including respiratory syncytial virus (RSV), are involved, or a pharmaceutically acceptable salt thereof. Specifically, the present invention provides a compound represented by formula (I): or a pharmaceutically acceptable salt thereof.

Abstract: A subject motion measuring apparatus includes at least one memory storing a program, and at least one processor which, by executing the program, causes the subject motion measuring apparatus to measure motion of a subject and output motion information related to the motion of the subject, reduce, from the motion information, an error caused by a disturbance other than the motion of the subject by using a trained model, and output the motion information in which the error is reduced. The trained model has functions of receiving a data set including the motion information with a plurality of degrees of freedom and outputting the motion information with the plurality of degrees of freedom in which the error is reduced.

Abstract: A subject motion measuring apparatus includes a camera for imaging a subject, at least one memory storing a program, and at least one processor which, by executing the program, causes the subject motion measuring apparatus to acquire three-dimensional coordinate data on a patch set in frame data included in moving image data imaged by the camera. The processor tracks the patch in the moving image data imaged by the camera and generates motion data on the subject on the basis of the three-dimensional coordinate data on the tracked patch.

Abstract: A medical image diagnostic apparatus includes a marker to be placed on a subject, at least one imaging unit configured to capture images of the subject and the marker, and a detection unit configured to detect movement of the marker from the images captured by the imaging unit. The marker includes a plurality of planar structures that can be detected by the detection unit, and the planar structures are spaced apart from each other with a distance no less than a predetermined distance.

Abstract: To provide a fluororesin laminate in which a layer of a fluorinated copolymer and a layer of a propylene polymer excellent in heat resistance are strongly attached. A laminate comprising a layer which contains a fluorinated copolymer having an adhesive functional group and having monomer unit based on tetrafluoroethylene and monomer units based on ethylene, and a layer which contains a propylene polymer having an adhesive functional group.

Abstract: A resin powder having a high bulk density and an average particle size of at most 50 ?m from resin particles containing a fluorocopolymer as the main component and having a melting point of 260 to 320° C., where the fluorocopolymer contains a unit containing a carbonyl group-containing group, a unit based on tetrafluoroethylene, and a unit based on a perfluoro(alkyl vinyl ether) or a unit based on hexafluoropropylene. A method of producing the resin powder by subjecting resin particles (A) having an average particle size of at least 100 ?m to mechanical pulverization treatment. The resin particles (A) is made of a material (X) having a fluorocopolymer (X1) as the main component, which has a unit (1) based on a monomer containing at least one functional group selected from a carbonyl group-containing group, a hydroxy group, an epoxy group and an isocyanate group, and a unit (2) based on tetrafluoroethylene.

Abstract: A nerve stimulating apparatus includes a plurality of stimulating units configured to respectively apply stimuli to a plurality of nerve regions branching from a particular nerve region of a living body, and a stimulation timing controller configured to set generating timings of respectively generating the stimuli at the plurality of stimulating units. The stimulation timing controller sets the generating timings of generating the stimuli at the plurality of stimulating units based on response results of the particular nerve region, the response results being obtained in response to the stimuli that are respectively generated at the plurality of stimulating units and that are respectively applied to the plurality of nerve regions, and the response results being measured by a biometric information measuring apparatus that measures biometric information.

Abstract: A material for a printed circuit board, which is a film composed of a fluorinated resin layer, where the fluorinated resin layer contains a composition containing a fluorinated copolymer having at least one functional group selected from a carbonyl group-containing group, a hydroxy group, an epoxy group and an isocyanate group, has a melt flow rate of at most 15 g/10 min measured at 372° C. under a load of 49N, and has a storage elastic modulus of at least 650 MPa.

Abstract: A material having a fluorinated resin layer is subjected to heat treatment. The fluorinated resin layer is composed of a composition containing a fluorinated copolymer (a) having at least one type of functional group selected from a carbonyl group-containing group, a hydroxy group, an epoxy group and an isocyanate group, having a melting point of from 280 to 320° C. and a melt flow rate of at least 2 g/10 min measured at 372° C. under a load of 49 N. The heat treatment is carried out at a temperature of at least 250° C. and lower by at least 5° C. than the melting point of the fluorinated copolymer (a) so that the ratio of the melt flow rate of the fluorinated resin layer after the heat treatment to that before the heat treatment, and the melt flow rate of the fluorinated resin layer after the heat treatment, are respectively within specific ranges.

Abstract: A non-transitory computer readable medium stores executable instructions that cause a computer to execute: transmitting, to a server, an image of an absorbent article containing vaginal discharge of a user; receiving, from the server, health information that is obtained from the image and indicates a health condition of the user; and displaying, on a display, a health information screen based on the health information. The health information screen displays a first message that indicates the health condition and a second message for improving the health condition.

Abstract: An object of the present invention is to provide a method of producing a peptide containing a charged non-proteinogenic amino acid in a cell-free translation system, and the like. The present invention provides a method of producing a peptide containing a charged non-proteinogenic amino acid. It includes a step of expressing a peptide in a cell-free translation system including (i) at least one tRNA to which a non-proteinogenic amino acid having a protecting-group-introduced charged group has been bound and (ii) a nucleic acid that encodes the peptide and contains at least one codon corresponding to an anticodon of the tRNA; and a step of removing the protecting group of the non-proteinogenic amino acid residue contained in the peptide.